Retrospective case series identifies MRI signals as potential markers of leptomeningeal metastasis in lung adenocarcinoma patients, suggesting further evaluation with CSF analysis.
Introduction: Leptomeningeal metastasis (LM) is a severe complication of solid malignancies, including lung adenocarcinoma, characterized by poor prognosis and diagnostic challenges. This study assesses whether curvilinear peri-brainstem hyperintense signals on MRI are a characteristic feature of LM in lung adenocarcinoma patients. Methods: This retrospective study analyzed data from multiple centers, encompassing lung adenocarcinoma patients with peri-brainstem curvilinear hyperintense signals on MRI between January 2016 and March 2022. Clinical and radiological data were reviewed, and diagnostic and survival outcomes were analyzed. Results: Eleven patients (45-76 years; 6 males and 5 females) were included. The mean interval from lung adenocarcinoma diagnosis to detection of brainstem signal was 1.59 years. Four patients had elevated carcinoembryonic antigen levels, and 6 showed systemic metastases. MRI revealed curvilinear hyperintense signals along the pons, medulla, and cerebral peduncles on T2-Weighted Imaging (T2WI), Fluid-Attenuated Inversion Recovery (FLAIR), and Diffusion-Weighted Imaging (DWI). Mild linear enhancement was observed in 4 of 6 patients undergoing contrastenhanced MRI, and tumor cells were detected in 4 of 6 Cerebrospinal Fluid (CSF) samples. The mean survival time in 7 patients with follow-up data was 3.42 months. Two patients exhibited peri-brainstem calcifications on CT 4–6 months after MRI and died shortly after. Discussion: These findings suggest that peri-brainstem curvilinear hyperintense signals and mild linear enhancement may serve as radiological markers of LM in lung adenocarcinoma. This pattern may reflect tumor infiltration or secondary changes in the leptomeninges. Conclusion: Peri-brainstem curvilinear hyperintense signals and mild linear enhancement on T2WI, FLAIR, and DWI may be characteristic of LM in lung adenocarcinoma. These findings suggest further evaluation with contrast-enhanced MRI or CSF analysis for confirmation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: